A goat poxvirus-vectored peste-des-petits-ruminants vaccine induces long-lasting neutralization antibody to high levels in goats and sheep

Vaccine

Volumn 28, Issue 30, 2010, Pages 4742-4750

  Chen, Weiye ^a   Hu, Sen ^a   Qu, Linmao ^a,b   Hu, Qianqian ^a,b   Zhang, Qian ^a   Zhi, Haibing ^c   Huang, Kehe ^b   Bu, Zhigao ^a  

^a INSTITUTE OF PLANT PROTECTION   (China)

^b NANJING AGRICULTURAL UNIVERSITY   (China)

^c CHINA INSTITUTE OF VETERINARY DRUG CONTROL   (China)

Author keywords

Peste des petits ruminants; Recombinant capripoxvirus; Vaccine

Indexed keywords

LIVE VACCINE; NEUTRALIZING ANTIBODY; VIRUS GLYCOPROTEIN; VIRUS VACCINE; VIRUS VECTOR; GLYCOPROTEIN; RECOMBINANT VACCINE; VIRUS ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; GOAT; IMMUNIZATION; IMMUNOGENICITY; NONHUMAN; PESTE DES PETITS RUMINANTS; POXVIRUS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEROCONVERSION; SHEEP; VIRUS RECOMBINANT; VIRUS VIRULENCE; ANIMAL; CAPRIPOXVIRUS; FLUORESCENT ANTIBODY TECHNIQUE; GENE VECTOR; GENETICS; GOAT DISEASES; IMMUNOLOGY; PESTE-DES-PETITS-RUMINANTS; PESTE-DES-PETITS-RUMINANTS VIRUS; PLASMID; SERODIAGNOSIS; SHEEP DISEASES; SUBCUTANEOUS DRUG ADMINISTRATION; VACCINATION; VETERINARY;

ANIMALS; ANTIBODIES, VIRAL; CAPRIPOXVIRUS; FLUORESCENT ANTIBODY TECHNIQUE; GENETIC VECTORS; GLYCOPROTEINS; GOAT DISEASES; GOATS; IMMUNIZATION, SECONDARY; INJECTIONS, SUBCUTANEOUS; NEUTRALIZATION TESTS; PESTE-DES-PETITS-RUMINANTS; PESTE-DES-PETITS-RUMINANTS VIRUS; PLASMIDS; SHEEP; SHEEP DISEASES; VACCINATION; VACCINES, ATTENUATED; VACCINES, SYNTHETIC;

EID: 77954214432     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2010.04.102     Document Type: Article

References (45)

1. Diallo A., Minet C., Le Goff C., Berhe G., Albina E., Libeau G., et al. The threat of peste des petits ruminants: progress in vaccine development for disease control. Vaccine 2007, 25:5591-5597.
2. Gargadennec L., Lalanne A. La peste des petits ruminants. Bull Serv Zoot Epiz AOF 1942, 5:16-21.
3. El Hag Ali B., Taylor W.P. Isolation of peste des petits ruminants virus from Sudan. Res Vet Sci 1984, 36:1-4.
4. Elzein E.M., Housawi F.M., Bashareek Y., Gameel A.A., Al-Afaleq A.I., Anderson E. Severe PPR infection in gazelles kept under semi-free range conditions. J Vet Med B Infect Dis Vet Public Health 2004, 51:68-71.
5. Ozkul A., Akca Y., Alkan F., Barrett T., Karaoglu T., Dagalp S.B., et al. Prevalence, distribution, and host range of peste des petits ruminants virus, Turkey. Emerg Infect Dis 2002, 8:708-712.
6. Lefevre P.C., Diallo A. Peste des petits ruminants. Rev Sci Tech 1990, 9:935-981.
7. Amjad H., Qamar ul I., Forsyth M., Barrett T., Rossiter P.B. Peste des petits ruminants in goats in Pakistan. Vet Rec 1996, 139:118-119.
8. Kwiatek O., Minet C., Grillet C., Hurard C., Carlsson E., Karimov B., et al. Peste des petits ruminants (PPR) outbreak in Tajikistan. J Comp Pathol 2007, 136:111-119.
9. Wang Z., Bao J., Wu X., Liu Y., Li L., Liu C., et al. Peste des petits ruminants virus in Tibet, China. Emerg Infect Dis 2009, 15:299-301.
10. Tulman E.R., Afonso C.L., Lu Z., Zsak L., Kutish G.F., Rock D.L. Genome of lumpy skin disease virus. J Virol 2001, 75:7122-7130.
11. Tulman E.R., Afonso C.L., Lu Z., Zsak L., Sur J.H., Sandybaev N.T., et al. The genomes of sheeppox and goatpox viruses. J Virol 2002, 76:6054-6061.
12. Babiuk S., Bowden T.R., Boyle D.B., Wallace D.B., Kitching R.P. Capripoxviruses: an emerging worldwide threat to sheep, goats and cattle. Transbound Emerg Dis 2008, 55:263-272.
13. Carn V.M. Control of capripoxvirus infections. Vaccine 1993, 11:1275-1279.
14. Romero C.H., Barrett T., Evans S.A., Kitching R.P., Gershon P.D., Bostock C., et al. Single capripoxvirus recombinant vaccine for the protection of cattle against rinderpest and lumpy skin disease. Vaccine 1993, 11:737-742.
15. Romero C.H., Barrett T., Kitching R.P., Carn V.M., Black D.N. Protection of cattle against rinderpest and lumpy skin disease with a recombinant capripoxvirus expressing the fusion protein gene of rinderpest virus. Vet Rec 1994, 135:152-154.
16. Romero C.H., Barrett T., Chamberlain R.W., Kitching R.P., Fleming M., Black D.N. Recombinant capripoxvirus expressing the hemagglutinin protein gene of rinderpest virus: protection of cattle against rinderpest and lumpy skin disease viruses. Virology 1994, 204:425-429.
17. Ngichabe C.K., Wamwayi H.M., Barrett T., Ndungu E.K., Black D.N., Bostock C.J. Trial of a capripoxvirus -rinderpest recombinant vaccine in African cattle. Epidemiol Infect 1997, 118:63-70.
18. Ngichabe C.K., Wamwayi H.M., Ndungu E.K., Mirangi P.K., Bostock C.J., Black D.N., et al. Long term immunity in African cattle vaccinated with a recombinant capripox-rinderpest virus vaccine. Epidemiol Infect 2002, 128:343-349.
19. Perrin A., Albina E., Breard E., Sailleau C., Prome S., Grillet C., et al. Recombinant capripoxviruses expressing proteins of bluetongue virus: evaluation of immune responses and protection in small ruminants. Vaccine 2007, 25:6774-6783.
20. Boone J.D., Balasuriya U.B., Karaca K., Audonnet J.C., Yao J., He L., et al. Recombinant canarypox virus vaccine co-expressing genes encoding the VP2 and VP5 outer capsid proteins of bluetongue virus induces high level protection in sheep. Vaccine 2007, 25:672-678.
21. Berhe G., Minet C., Le Goff C., Barrett T., Ngangnou A., Grillet C., et al. Development of a dual recombinant vaccine to protect small ruminants against peste-des-petits-ruminants virus and capripoxvirus infections. J Virol 2003, 77:1571-1577.
22. Diallo A., Minet C., Berhe G., Le Goff C., Black D.N., Fleming M., et al. Goat immune response to capripox vaccine expressing the hemagglutinin protein of peste des petits ruminants. Ann N Y Acad Sci 2002, 969:88-91.
23. Gibbs E.P., Taylor W.P., Lawman M.J., Bryant J. Classification of peste des petits ruminants virus as the fourth member of the genus Morbillivirus. Intervirology 1979, 11:268-274.
24. Choppin P.W., Scheid A. The role of viral glycoproteins in adsorption, penetration, and pathogenicity of viruses. Rev Infect Dis 1980, 2:40-61.
25. Merz D.C., Scheid A., Choppin P.W. Immunological studies of the functions of paramyxovirus glycoproteins. Virology 1981, 109:94-105.
26. Giraudon P., Wild T.F. Correlation between epitopes on hemagglutinin of measles virus and biological activities: passive protection by monoclonal antibodies is related to their hemagglutination inhibiting activity. Virology 1985, 144:46-58.
27. Malvoisin E., Wild F. Contribution of measles virus fusion protein in protective immunity: anti-F monoclonal antibodies neutralize virus infectivity and protect mice against challenge. J Virol 1990, 64:5160-5162.
28. Fournier P., Brons N.H., Berbers G.A., Wiesmuller K.H., Fleckenstein B.T., Schneider F., et al. Antibodies to a new linear site at the topographical or functional interface between the haemagglutinin and fusion proteins protect against measles encephalitis. J Gen Virol 1997, 78:1295-1302.
29. Libeau G., Prehaud C., Lancelot R., Colas F., Guerre L., Bishop D.H., et al. Development of a competitive ELISA for detecting antibodies to the peste des petits ruminants virus using a recombinant nucleoprotein. Res Vet Sci 1995, 58:50-55.
30. Singh R.P., Sreenivasa B.P., Dhar P., Bandyopadhyay S.K. A sandwich-ELISA for the diagnosis of peste des petits ruminants (PPR) infection in small ruminants using anti-nucleocapsid protein monoclonal antibody. Arch Virol 2004, 149:2155-2170.
31. World Organization for Animal Health. Manual of Diagnostic Tests & Vaccines for Terrestrial Animals. 6th ed. Paris; 2008.
32. Chakrabarti S., Brechling K., Moss B. Vaccinia virus expression vector: coexpression of β-galactosidase provides visual screening of recombinant virus plaques. Mol Cell Biol 1985, 5:3403-3409.
33. Boyle D.B., Coupar B.E. A dominant selectable marker for the construction of recombinant poxviruses. Gene 1988, 65:123-128.
34. Falkner F.G., Moss B. Escherichia coli gpt gene provides dominant selection for vaccinia virus open reading frame expression vectors. J Virol 1988, 62:1849-1854.
35. Yilma T., Hsu D., Jones L., Owens S., Grubman M., Mebus C., et al. Protection of cattle against rinderpest with vaccinia virus recombinants expressing the HA or F gene. Science 1988, 242:1058-1061.
36. Giavedoni L., Jones L., Mebus C., Yilma T. A vaccinia virus double recombinant expressing the F and H genes of rinderpest virus protects cattle against rinderpest and causes no pock lesions. Proc Natl Acad Sci U S A 1991, 88:8011-8015.
37. Ohishi K., Inui K., Barrett T., Yamanouchi K. Long-term protective immunity to rinderpest in cattle following a single vaccination with a recombinant vaccinia virus expressing the virus haemagglutinin protein. J Gen Virol 2000, 81:1439-1446.
38. Verardi P.H., Aziz F.H., Ahmad S., Jones L.A., Beyene B., Ngotho R.N., et al. Long-term sterilizing immunity to rinderpest in cattle vaccinated with a recombinant vaccinia virus expressing high levels of the fusion and hemagglutinin glycoproteins. J Virol 2002, 76:484-491.
39. Guillaume V., Contamin H., Loth P., Georges-Courbot M.C., Lefeuvre A., Marianneau P., et al. Nipah virus: vaccination and passive protection studies in a hamster model. J Virol 2004, 78:834-840.
40. Weingartl H.M., Berhane Y., Caswell J.L., Loosmore S., Audonnet J.C., Roth J.A., et al. Recombinant nipah virus vaccines protect pigs against challenge. J Virol 2006, 80:7929-7938.
41. Wang X., Ge J., Hu S., Wang Q., Wen Z., Chen H., et al. Efficacy of DNA immunization with F and G protein genes of Nipah virus. Ann N Y Acad Sci 2006, 1081:243-245.
42. Wallace D.B., Viljoen G.J. Importance of thymidine kinase activity for normal growth of lumpy skin disease virus (SA-Neethling). Arch Virol 2002, 147:659-663.
43. Wallace D.B., Weyer J., Nel L.H., Viljoen G.J. Improved method for the generation and selection of homogeneous lumpy skin disease virus (SA-Neethling) recombinants. J Virol Methods 2007, 146:52-60.
44. Gao W., Soloff A.C., Lu X., Montecalvo A., Nguyen D.C., Matsuoka Y., et al. Protection of mice and poultry from lethal H5N1 avian influenza virus through adenovirus-based immunization. J Virol 2006, 80:1959-1964.
45. Ge J., Deng G., Wen Z., Tian G., Wang Y., Shi J., et al. Newcastle disease virus-based live attenuated vaccine completely protects chickens and mice from lethal challenge of homologous and heterologous H5N1 avian influenza viruses. J Virol 2007, 81:150-158.